SCHEMBL26062360

SCHEMBL26062360

c1ccc(-c2cccc(N(c3ccc(-c4cc5ccccc5c5ccccc45)cc3)c3cccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.43
HSD17B2 P37059 3/20 0.43
CYP11B1 P15538 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
MPI P34949 1/20 0.39
KMT2A Q03164 1/20 0.39
HPRT1 P00492 3/20 0.38
GPR84 Q9NQS5 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
ESR1 P03372 3/20 0.37
ESR2 Q92731 3/20 0.37
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26055102 1.00 HSD17B1 (0.43) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL22670380 1.00 HSD17B1 (0.43) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL26062357 0.99 HSD17B1 (0.43) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23472044 0.97 HSD17B1 (0.40) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL23659598 0.96 HSD17B1 (0.40) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL26054487 0.96 HSD17B1 (0.39) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL26053911 0.96 HSD17B1 (0.39) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL26054702 0.96 HSD17B1 (0.39) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL24657452 0.95 HSD17B1 (0.39) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD
SCHEMBL25088643 0.95 CA12 (0.41) HSD17B1HSD17B2CYP11B1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2024-01-25 US disclosed
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2024-01-25 US disclosed
EP-4235829-A1 ORGANIC LIGHT-EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-08-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025840-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, TMEM109 HSD17B1 464/4885HSD17B2 743/4885CYP11B1 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.